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Xcellerex XDR-500 MO single-use fermentor for microbial processes
™

József Vasi, Andreas Castan and Sandeep Kristiansson
GE Healthcare Bio-Sciences AB, Björkgatan 30, 75184 Uppsala, Sweden

Single-use bioreactors are well-established in mammalian cell-based biopharmaceutical productions. However, adoption of
single-use technologies for microbial/yeast-based production has been slow due to the unique requirements of fermentation
processes. The typical challenges include supporting high-cell density cultivations, high oxygen transfer capacity, and
efficient heat removal.

Improved process understanding during transition to SUB indicated substrate overfeeding in the SS bioreactor. Evaluation of
three reduced feed regimes showed that even applying as low as 60% of the original feed rate to XDR-500 MO was sufficient to
maintain cell growth, as shown for XDR-Run 3 in Figure 1, and product formation was found to be at comparable levels to the
original process. The reduced substrate feed also led to decreased oxygen consumption rate.

Here, we present the single-use XDR-500 MO stirred-tank fermentor system specifically designed for microbial/yeast
applications. The performance of the fermentor was evaluated using an E. coli fed-batch process producing a domain
antibody (dAb) as a model system. The process was originally developed for a lab-scale conventional stainless steel (SS)
system. This work describes the strategy applied to transfer and scale-up this process to the single-use bioreactor (SUB)
without the need for extensive re-optimization due to technology change. Moreover, process economy of dAb production
based on single-use and conventional technology was compared in silico.

Levels of expressed dAb achieved in XDR-500 MO after process transfer and scale-up were reproducible and comparable with the
SS bioreactor (Fig 2) even without process optimization. Furthermore, it was shown that dAb concentration increased linearly after
induction (Fig 3), indicating a straightforward strategy to improve product titer.
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Fed-batch process for E. coli RV308 clone expressing a dAb, originally developed for lab-scale conventional SS bioreactor,
was transferred and scaled up to XDR-500 MO SUB. Mineral salt medium complemented with yeast extract in combination
with 60% (w/v) glycerol substrate feed was used for cultivations. Process parameters critical for dAb expression were kept
constant between technologies, while others were adapted to single-use technology (Table 1). Dissolved oxygen level was
cascade controlled by stirrer speed, airflow, and oxygen enrichment of airflow in the single-use system.
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Cell densities and dAb expression levels similar to the lab-scale conventional bioreactor were achieved in XDR-500 MO,
confirming feasibility of single-use technology even in microbial processes.

Materials and methods

Critical process parameters like dissolved oxygen level, pH, and temperature were controlled efficiently within their targeted range
under the entire cultivation. Temperature was maintained at 37˚C ± 0.1˚C even when metabolic heat generation peaked at 38 000
BTU/h. Instead of increasing headspace pressure, DO was maintained with oxygen enrichment, enabling cell growth to high cell
densities (Fig 4).
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Fig 1. Cell growth in XDR-500 MO at studied feed rates. Cell growth even
at lowest feed rate was comparable with stainless steel bioreactor.

Substrate feeding strategy was adapted to the SUB and three different rates were evaluated.
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Fig 2. Comparison dAb expression levels obtained in single-use XDR-500 MO
and stainless steel reactors. Product concentrations were determined after
5 h induction time.
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Fig 3. Effect of extended induction time on dAb expression.
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Fig 4. Parameter chart of a typical dAb cultivation in the single-use
XDR-500 MO.

Medium and feed solutions were prepared in Xcellerex XDUO mixer bags and sterile filtered into the to single-use bioreactor.
All cultures have been induced at an OD600nm of 80.

Conclusions

Comparison of process economy between single-use and
conventional SS production facilities for dAb manufacturing
revealed up to twice as high facility utilization when
producing in a single-use system (Table 2).

• XDR-500 MO allowed robust control of challenging
process parameters (DO, pH, temperature).

According to our model, at 4–15 annual batches (e.g., for
toxicology or early clinical phase studies), it is more costeffective to manufacture in a single-use facility compare
with a conventional facility (Fig 5).
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• The model process successfully transferred and scaled
up from SS bioreactor to SUB without the need for
extensive modifications.
• Cell growth and dAb production level were comparable
across technologies/scales even with the implemented
changes.
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• Higher production flexibility and facility utilization can
be achieved with single-use systems.
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Fig 5. Total production cost to number of batches produced annually
in single-use and stainless steel facilities.
Table 1. Process transfer and scale-up strategy

Table 2. Comparison of process economy for dAb production between XDR-500 MO SUB and SS bioreactor (scenarios for single and multiple
product facilities were evaluated)

Process parameters
Kept constant

Adjusted

Parameter

pH and DO set points

DO control strategy

Type of Bioreactor

SS

SUB

SS

SUB

Medium and feed composition

Medium and feed preparation procedures

Maximum number of batches

100

150

67

135

Induction conditions

Substrate feed profile

Relative cost comparison

1×

1.47×

1×

1.40×

Relative facility utilization

1×

1.5×

1×

2×

Temperature set point
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Scenario 1 – Single product facility

Scenario 2 – Multi product facility

• Single-use systems are viable alternatives to
conventional SS bioreactors for microbial processes.

